Health Psychology Research Unit (HPRU) is an independent research unit, headed by Clare Bradley, Professor of Health Psychology. It is based in the Orchard Building at Royal Holloway, University of London.
HPR Limited (HPR Ltd), the commercial arm of Health Psychology Research Unit (HPRU), manages the licensing of questionnaires for use by other researchers and clinicians in clinical trials, as well as other research studies, routine audit and clinical practice.
The activities of HPRU and HPR Ltd are closely linked: HPR Ltd funds some of the research and development work of HPRU.
HPR Ltd is based in offices close to the Royal Holloway campus, in Egham. Royal Holloway is located about 20 miles west of Central London and about 5 miles from Heathrow Airport.
Professor Clare Bradley - Managing Director
Professor Clare Bradley is Head of the Health Psychology Research Unit which includes the Diabetes Research Group and Renal Research Group plus additional health-related research projects.
The research and professional activities have two main themes:
- Design, development, use, interpretation, linguistic validation and evaluation of psychological measures of processes and outcomes in management of chronic medical conditions, alongside biomedical measures.
- Design, analysis and interpretation of clinical trials taking account of patient preferences and other psychological factors affecting biomedical and psychological outcomes.
Both themes share a common goal of increasing the attention given to psychological processes and patients' psychological outcomes and integrating these considerations with biomedical concerns with a view to improving patient care in terms of health outcomes and quality of life.
The special contributions of work conducted to date include:
- The development of diabetes-specific psychological measures which have proved to have greater reliability, validity and responsiveness to changes of interest in diabetes than have generic instruments. The success of the instruments is reflected by:
- Funding to provide comparable measures for other conditions
- Endorsement and use of instruments by the World Health Organisation and International Diabetes Federation
- The many contracts with all the major pharmaceutical companies using the scales
- Linguistic validation of the measures into more than 110 languages world-wide (click here to see lists of current languages and countries)
- The promotion of a paradigm shift away from the widespread acceptance of randomised controlled clinical trial designs for the evaluation of new treatments requiring the active involvement of patients, towards trial designs which take account of patients' preferences for the treatments to be studied; notably partially-randomised patient-centred designs (first suggested by Clare Bradley and Chris Brewin in 1989 - BMJ 299) which have been employed in a number of major clinical trials.
Jonathan Gilbride - Commercial Director
The commercial director and company secretary of HPR Ltd is Jonathan Gilbride, who has extensive experience managing international companies. He deals primarily with all legal and commercial aspects of HPR's business. Contact him at firstname.lastname@example.org
Alison Wilson - Linguistic Validation Department
Alison manages linguistic validation projects and is responsible for the final formatting of new questionnaires. She ensures that sample versions are available to view on the website as part of her role in maintaining the HPR website. email@example.com
Janet assists Jonathan on a part-time basis, dealing primarily with non-commercial and student licences. firstname.lastname@example.org